Zobrazeno 1 - 10
of 2 397
pro vyhledávání: '"Caraco, Y."'
Autor:
Caraco Y; Clinical Pharmacology Unit, Haddasah Medical Center, Ein Karem, Jerusalem Israel., Wanounou M; Clinical Pharmacology Unit, Haddasah Medical Center, Ein Karem, Jerusalem Israel., Blotnick S; Clinical Pharmacology Unit, Haddasah Medical Center, Ein Karem, Jerusalem Israel., Friedman L; SpliSense, Minrav Building, Haddasah Ein Kerem, Jerusalem, Israel., Cohen A; SpliSense, Minrav Building, Haddasah Ein Kerem, Jerusalem, Israel., Hart G; SpliSense, Minrav Building, Haddasah Ein Kerem, Jerusalem, Israel. Electronic address: gili@splisense.com., Kerem E; CF Center, Haddasah Medical Center, Jerusalem Israel.
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2024 Nov 04. Date of Electronic Publication: 2024 Nov 04.
Autor:
Shaul C; Clinical Pharmacology Unit, Division of Medicine, Hadassah-Hebrew University Medical Center, POB 12000, 91120, Jerusalem, Israel.; Institute of Drug Research, School of Pharmacy, Faculty of Medicine, Hebrew University, Jerusalem, Israel., Blotnick S; Clinical Pharmacology Unit, Division of Medicine, Hadassah-Hebrew University Medical Center, POB 12000, 91120, Jerusalem, Israel., Adar L; Clinical Pharmacology Unit, Division of Medicine, Hadassah-Hebrew University Medical Center, POB 12000, 91120, Jerusalem, Israel.; Institute of Drug Research, School of Pharmacy, Faculty of Medicine, Hebrew University, Jerusalem, Israel., Muszkat M; Clinical Pharmacology Unit, Division of Medicine, Hadassah-Hebrew University Medical Center, POB 12000, 91120, Jerusalem, Israel., Bialer M; Institute of Drug Research, School of Pharmacy, Faculty of Medicine, Hebrew University, Jerusalem, Israel.; David R. Bloom Center for Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel., Caraco Y; Clinical Pharmacology Unit, Division of Medicine, Hadassah-Hebrew University Medical Center, POB 12000, 91120, Jerusalem, Israel. caraco@hadassah.org.il.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2022 Aug; Vol. 61 (8), pp. 1187-1198. Date of Electronic Publication: 2022 Jun 14.
Autor:
Tal Y; Allergy and Clinical Immunology Unit, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Ribak Y; Allergy and Clinical Immunology Unit, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Rubin L; Allergy and Clinical Immunology Unit, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Talmon A; Allergy and Clinical Immunology Unit, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Shamriz O; Allergy and Clinical Immunology Unit, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: oded.shamriz@mail.huji.ac.il., Hershko AY; Allergy and Clinical Immunology Unit, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Blotnick S; Clinical Pharmacology Unit, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., Bouhajib M; Pharma Medica Research Inc, Bioanalytical services, Mississauga, ON, Canada., Krayz GT; Formulex Pharma Innovation Ltd, Pharmaceutical development and manufacturing, Nes Ziona, Israel., Abrutzky C; Nasus Pharma, Tel Aviv, Israel., Megiddo D; Nasus Pharma, Tel Aviv, Israel., Lapidot T; Nasus Pharma, Tel Aviv, Israel. Electronic address: tair@nasuspharma.com., Caraco Y; Clinical Pharmacology Unit, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Publikováno v:
The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2023 Oct; Vol. 11 (10), pp. 3047-3054. Date of Electronic Publication: 2023 Jun 30.
Autor:
Weil C; Maccabi Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv 68125, Israel., Bergroth T; Center for Observational and Real-World Evidence (CORE), MSD, 113 30 Stockholm, Sweden., Eisenberg A; MSD, Hod Hasharon 45240, Israel., Whiteside YO; Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc., Rahway, NJ 07065, USA., Caraco Y; Clinical Pharmacology Unity, Hadassah-Hebrew University Medical Center, Jerusalem 911200, Israel., Tene L; Maccabi Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv 68125, Israel., Chodick G; Maccabi Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv 68125, Israel.; School of Public Health, Faculty of Medicine, Tel Aviv University, Ramat Aviv 6997801, Israel.
Publikováno v:
Epidemiologia (Basel, Switzerland) [Epidemiologia (Basel)] 2023 Aug 10; Vol. 4 (3), pp. 309-321. Date of Electronic Publication: 2023 Aug 10.
Autor:
Kobo-Greenhut A; Risk Management, Validation, Regulation, Haifa, Israel., Zohar-Beja A; Eating Disorder Department, Sheba Medical Center, Tel HaShomer, Israel., Hadar L; SipNose Ltd., Yokneam, Israel., Itzhaki L; SipNose Ltd., Yokneam, Israel., Karasik A; SipNose Ltd., Yokneam, Israel., Caraco Y; Clinical Pharmacology Unit, Division of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Frankenthal H; Ziv Medical Center, Safed, Israel.; Zefat Academic College, Safed, Israel., Shahaf D; SipNose Ltd., Yokneam, Israel., Ekstein D; Department of Neurology and Agnes Ginges Center for Neurogenetics, Hadassah Medical Center, Jerusalem, Israel.; Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Shichor I; SipNose Ltd., Yokneam, Israel. iris@sipnose.com., Gur E; Eating Disorder Department, Sheba Medical Center, Tel HaShomer, Israel.
Publikováno v:
Journal of eating disorders [J Eat Disord] 2023 Jun 26; Vol. 11 (1), pp. 102. Date of Electronic Publication: 2023 Jun 26.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Journal of Cystic Fibrosis October 2023 22 Supplement 3:S61-S61
Autor:
Gotkine M; Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Caraco Y; Hadassah Clinical Research Center (HCRC), Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Lerner Y; Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Blotnick S; Hadassah Clinical Research Center (HCRC), Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Wanounou M; Hadassah Clinical Research Center (HCRC), Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Slutsky SG; Neurodegenerative Diseases Department, Kadimastem Ltd, Pinchas Sapir 7, Weizmann Science Park, Ness-Ziona, Israel., Chebath J; Neurodegenerative Diseases Department, Kadimastem Ltd, Pinchas Sapir 7, Weizmann Science Park, Ness-Ziona, Israel., Kuperstein G; Neurodegenerative Diseases Department, Kadimastem Ltd, Pinchas Sapir 7, Weizmann Science Park, Ness-Ziona, Israel., Estrin E; Neurodegenerative Diseases Department, Kadimastem Ltd, Pinchas Sapir 7, Weizmann Science Park, Ness-Ziona, Israel., Ben-Hur T; Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Hasson A; Neurodegenerative Diseases Department, Kadimastem Ltd, Pinchas Sapir 7, Weizmann Science Park, Ness-Ziona, Israel., Molakandov K; Neurodegenerative Diseases Department, Kadimastem Ltd, Pinchas Sapir 7, Weizmann Science Park, Ness-Ziona, Israel., Sonnenfeld T; Neurodegenerative Diseases Department, Kadimastem Ltd, Pinchas Sapir 7, Weizmann Science Park, Ness-Ziona, Israel., Stark Y; Neurodegenerative Diseases Department, Kadimastem Ltd, Pinchas Sapir 7, Weizmann Science Park, Ness-Ziona, Israel., Revel A; Neurodegenerative Diseases Department, Kadimastem Ltd, Pinchas Sapir 7, Weizmann Science Park, Ness-Ziona, Israel., Revel M; Neurodegenerative Diseases Department, Kadimastem Ltd, Pinchas Sapir 7, Weizmann Science Park, Ness-Ziona, Israel.; Department of Molecular Genetics, Weizmann Institute of Science, 76100, Rehovot, Israel., Izrael M; Neurodegenerative Diseases Department, Kadimastem Ltd, Pinchas Sapir 7, Weizmann Science Park, Ness-Ziona, Israel. M.izrael@kadimastem.com.
Publikováno v:
Journal of translational medicine [J Transl Med] 2023 Feb 14; Vol. 21 (1), pp. 122. Date of Electronic Publication: 2023 Feb 14.
Autor:
Shebley M; AbbVie Inc., North Chicago, Illinois, USA., Wang S; AbbVie Inc., North Chicago, Illinois, USA., Ali I; AbbVie Inc., North Chicago, Illinois, USA., Krishnan P; AbbVie Inc., North Chicago, Illinois, USA., Tripathi R; AbbVie Inc., North Chicago, Illinois, USA., Reardon JM; Prisma Health Upstate, Greenville, South Carolina, USA., Cafardi J; The Christ Hospital, Cincinnati, Ohio, USA., Rahav G; Sheba Medical Center and Tel-Aviv University, Tel Hashomer, Israel., Caraco Y; Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Slim J; NYMC, Valhalla, New York, USA., Al Akhrass F; Pikeville Medical Center, Pikeville, Kentucky, USA., Yu M; AbbVie Inc., North Chicago, Illinois, USA., Hu Y; AbbVie Inc., North Chicago, Illinois, USA., Ferreira RA; AbbVie Inc., North Chicago, Illinois, USA., Alami NN; AbbVie Inc., North Chicago, Illinois, USA.
Publikováno v:
Pharmacology research & perspectives [Pharmacol Res Perspect] 2023 Feb; Vol. 11 (1), pp. e01036.
Autor:
Kerem, E.1,2 (AUTHOR), Caraco, Y.3 (AUTHOR), Wanounou, M.3 (AUTHOR), Friedman, L.2 (AUTHOR), Cohen, A.2 (AUTHOR), Hart, G.2 (AUTHOR)
Publikováno v:
Journal of Cystic Fibrosis. 2024 Supplement 1, Vol. 23, pS11-S11. 1p.